These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 18092806)
1. Nile Red is a fluorescent allosteric substrate of cytochrome P450 3A4. Lampe JN; Fernandez C; Nath A; Atkins WM Biochemistry; 2008 Jan; 47(2):509-16. PubMed ID: 18092806 [TBL] [Abstract][Full Text] [Related]
2. Spectral resolution of a second binding site for Nile Red on cytochrome P4503A4. Nath A; Fernández C; Lampe JN; Atkins WM Arch Biochem Biophys; 2008 Jun; 474(1):198-204. PubMed ID: 18395506 [TBL] [Abstract][Full Text] [Related]
3. Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives. Shou M; Mei Q; Ettore MW; Dai R; Baillie TA; Rushmore TH Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):845-53. PubMed ID: 10359672 [TBL] [Abstract][Full Text] [Related]
5. Pyrene.pyrene complexes at the active site of cytochrome P450 3A4: evidence for a multiple substrate binding site. Dabrowski MJ; Schrag ML; Wienkers LC; Atkins WM J Am Chem Soc; 2002 Oct; 124(40):11866-7. PubMed ID: 12358527 [TBL] [Abstract][Full Text] [Related]
6. Allosteric effects on substrate dissociation from cytochrome P450 3A4 in nanodiscs observed by ensemble and single-molecule fluorescence spectroscopy. Nath A; Koo PK; Rhoades E; Atkins WM J Am Chem Soc; 2008 Nov; 130(47):15746-7. PubMed ID: 18980315 [TBL] [Abstract][Full Text] [Related]
7. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs. Brandes LJ; Queen GM; LaBella FS Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318 [TBL] [Abstract][Full Text] [Related]
8. The thermodynamic landscape of testosterone binding to cytochrome P450 3A4: ligand binding and spin state equilibria. Roberts AG; Campbell AP; Atkins WM Biochemistry; 2005 Feb; 44(4):1353-66. PubMed ID: 15667229 [TBL] [Abstract][Full Text] [Related]
9. Allosteric mechanisms in cytochrome P450 3A4 studied by high-pressure spectroscopy: pivotal role of substrate-induced changes in the accessibility and degree of hydration of the heme pocket. Davydov DR; Baas BJ; Sligar SG; Halpert JR Biochemistry; 2007 Jul; 46(26):7852-64. PubMed ID: 17555301 [TBL] [Abstract][Full Text] [Related]
10. Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency. Polic V; Sevrioukova IF; Auclair K Arch Biochem Biophys; 2018 Sep; 653():90-96. PubMed ID: 29958895 [TBL] [Abstract][Full Text] [Related]
11. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Gallagher EP; Kunze KL; Stapleton PL; Eaton DL Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785 [TBL] [Abstract][Full Text] [Related]
12. Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4. Isin EM; Guengerich FP J Biol Chem; 2006 Apr; 281(14):9127-36. PubMed ID: 16467307 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the fluorescent probes Nile Red and 25-NBD-cholesterol as substrates for steroid-converting oxidoreductases using pure enzymes and microorganisms. Faletrov YV; Frolova NS; Hlushko HV; Rudaya EV; Edimecheva IP; Mauersberger S; Shkumatov VM FEBS J; 2013 Jul; 280(13):3109-19. PubMed ID: 23551929 [TBL] [Abstract][Full Text] [Related]
14. Allosteric activation of cytochrome P450 3A4 by α-naphthoflavone: branch point regulation revealed by isotope dilution analysis. Woods CM; Fernandez C; Kunze KL; Atkins WM Biochemistry; 2011 Nov; 50(46):10041-51. PubMed ID: 22004098 [TBL] [Abstract][Full Text] [Related]
15. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling). Narasimhulu S Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838 [TBL] [Abstract][Full Text] [Related]
16. Identification of novel substrates for human cytochrome P450 2J2. Lee CA; Neul D; Clouser-Roche A; Dalvie D; Wester MR; Jiang Y; Jones JP; Freiwald S; Zientek M; Totah RA Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256 [TBL] [Abstract][Full Text] [Related]
17. Allosteric transitions in cytochrome P450eryF explored with pressure-perturbation spectroscopy, lifetime FRET, and a novel fluorescent substrate, Fluorol-7GA. Davydov DR; Davydova NY; Halpert JR Biochemistry; 2008 Oct; 47(43):11348-59. PubMed ID: 18831537 [TBL] [Abstract][Full Text] [Related]
18. Fluorescent photoaffinity labeling of cytochrome P450 3A4 by lapachenole: identification of modification sites by mass spectrometry. Wen B; Doneanu CE; Gartner CA; Roberts AG; Atkins WM; Nelson SD Biochemistry; 2005 Feb; 44(6):1833-45. PubMed ID: 15697209 [TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486). He K; Woolf TF; Hollenberg PF J Pharmacol Exp Ther; 1999 Feb; 288(2):791-7. PubMed ID: 9918590 [TBL] [Abstract][Full Text] [Related]
20. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast. Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]